Displaying items by tag: heart disease

You may be eligible to take part in this study if you have previously had a heart attack (myocardial infarction) or brain attack (stroke) or have been diagnosed with poor circulation. If you have reduced kidney function or if you have inflammation in your blood vessels ? The University of Alabama at Birmingham, Department of Nutrition Sciences, is conducting a 4 year research study to look if an investigational medicine ,called ‘ziltivekimab’ can be used to treat people with cardiovascular disease, chronic kidney disease and inflammation. Qualified participants will receive study drug at no cost and may be compensated for time and travel. For more information, and to see if you might be eligible to join, contact (205) 996-4015 or email at ccnrn@uab.edu.
You may be eligible to participate in a research study about the effects of Exercise and Metoprolol (a blood pressure pill) on a protein in your blood. This protein is related to heart disease. Eligible participants must be Healthy men and women, African American or Caucasians, and have no history of diabetes, heart problems, or kidney problems. The study involves performing the exercise, taking metoprolol, consuming prepared meals, and collecting blood samples. Participants will be compensated. Please e-mail Nehal Vekariya at exercisebetastudy@uabmc.edu or call us at 205-934-7173 if you are interested.
Clinical trial evaluating a novel, non-invasive radiation treatment for ventricular tachycardia refractory to medication and catheter ablation The UAB Departments of Radiation Oncology and Cardiology are looking for patients with ventricular tachycardia (VT) not controlled by medications and catheter ablation. The trial will allow patients suffering from VT despite standard of care regimens to undergo non-invasive cardiac radioablation (CRA; a type of stereotactic body radiotherapy) to the area of the heart responsible for their symptoms. Stereotactic body radiotherapy is delivered with a device called the linear accelerator, which is primarily used to treat patients with cancer. UAB is one of the first centers in the U.S. to obtain a Food and Drug Administration (FDA) investigational device exemption for use of the linear accelerator in this capacity on a phase I/II trial. The study is being conducted in collaboration with the Washington University School of Medicine in St. Louis, a center which pioneered this promising technique in the U.S. For more information on the RAD 1901 trial, please contact Adelyn Gillon, clinical research coordinator, at 205.975.3019 or agillon@uabmc.edu" contenteditable="false">agillon@uabmc.edu.
Rural Research Participants Needed FSU College of Nursing invites individuals with heart failure and their care partners who live in rural areas to participate in a research project under the direction of Lucinda J. Graven, Ph.D., APRN. Care teams will partner with a registered nurse to manage daily challenges related to heart failure self-care by telephone. Compensation up to $200 per care team who complete the telehealth program. Please contact Joan Grant Keltner, Ph.D., RN at (205) 934-6527 or grantj@uab.edu. For more information, you may also use: https://fsu.qualtrics.com/jfe/form/SV_3IPqQs7MAPmuHpH
Are you a healthy person ages 18-40? You may be eligible to participate in a research study about the effects of exercise and Metoprolol (a blood pressure pill) on a protein in your blood. This protein is related to heart disease. Eligible participants must be healthy men and women, African American or Caucasian with no history of diabetes, heart problems, or kidney problems. The study involves performing exercise, taking metoprolol, consuming prepared meals, and collecting blood samples. Participants will be compensated. Please email Dr. Nirav Patel, npatel@uabmc.edu if you are interested.
Are you a healthy person ages 18-40? You may be eligible to participate in a research study about the effects of Glucose on a protein in your blood. This protein is related to heart disease. Eligible participants must be healthy men and women, African American or Caucasians with no history of elevated blood pressure, diabetes, heart problems or kidney problems. The study involves consuming prepared meals and collecting blood samples. Participants will be compensated. Please e-mail Dr. Nirav Patel, npatel@uabmc.edu if you are interested.
Are you a healthy person ages 18-40? You may be eligible to participate in a research study about the effects of exercise and Metoprolol (a blood pressure pill) on a protein in your blood. This protein is related to heart disease. Eligible participants must be healthy men and women, African American or Caucasians with no history of diabetes, heart problems or kidney problems. The study involves performing exercise, taking metoprolol, consuming prepared meals, and collecting blood samples. Participants will be compensated. Please e-mail Dr. Nirav Patel, npatel@uabmc.edu if you are interested.
If you ages 18 and older AND have either heart failure (in the past 2 years) or a heart attack (in the past year) you may qualify for a research study. What happens in the study? • vaccination with either high dose (investigational for adults under the age of 65) OR standard dose flu shot, provided at no cost to you (once per year, up to 3 years); •monitoring any heart or lung related hospital visits; • telephone follow-up • optional blood draw. Patients who have already received their flu shot this year are not eligible to enroll. Participants will be compensated. For more information about how you can participate in INVESTED, please call the UAB Hypertension Program at 205-934-9281.
Healthy African American or Caucasian men and women ages 18-40 needed to participate in a research study about the effects of glucose on a protein in your blood — this protein is related to heart disease. Must have no history of elevated blood pressure, diabetes, heart problems or kidney problems. The study involves consuming prepared meals and collecting blood samples. Participants will be compensated. Please email Dr. Nirav Patel, npatel@uabmc.edu if you are interested.
Are you a healthy person ages 18-40? You may be eligible to participate in a research study about the effects of Exercise and Metoprolol (a blood pressure pill) on a protein in your blood. This protein is related to heart disease. Eligible participants must be Healthy men and women, African American or Caucasians and have no history of diabetes, heart problems, or kidney problems. The study involves performing exercise, taking metoprolol, consuming prepared meals, and collecting blood samples. Participants will be compensated. Please e-mail Dr. Nirav Patel, npatel@uabmc.edu if you are interested.
You may be eligible to participate in a research study about the effects of glucose on a protein in your blood. This protein is related to heart disease. Eligible participants must be healthy men and women, African American or Caucasians and have no history of elevated blood pressure, diabetes, heart problems or kidney problems. The study involves consuming prepared meals and collecting blood samples. Participants will be compensated. Please e-mail Dr. Nirav Patel, npatel@uabmc.edu if you are interested.
We are currently seeking cardiac surgical patients to participate in the LEVO-CTS research study. The purpose of the study is to evaluate an investigational drug with the potential to improve outcomes in patients undergoing coronary artery bypass and/or heart valve surgery. Minimum eligibility requirements: Must be 18 years or older, your physician has diagnosed you with coronary vessel disease requiring bypass surgery and/or the need for heart valve surgery. Talk to your cardiologist or your heart surgeon for additional information. Questions can also be answered by Alicia Kindred or D'Netria Jackson at 205-934-4711 or 205-975-2088.